Through the UALCAN tool, we further discovered that the expression level of ALKBH5 was significantly higher in metastatic melanoma than in primary melanoma, indicating that ALKBH5 may play a dominant part in cancer progression and metastasis in SKCM (Figure 1C). The gene discussed is ALKBH5; the disease is metastatic melanoma.